IMVT   $22.98  -2.83% Market Closed After Close 22.98 0.0

Immunovant, Inc.
Total Cash 560.00M
totalCashPerShare 3.826
EBITDA -298.26M
Total Debt 69.00K
quickRatio 12.493
currentRatio 13.085
Total Revenue
debtToEquity 0.013
Revenue/Share
ROA -0.39658
ROE -0.64545
grossProfits
freeCashflow -157.40M
operatingCashflow -243.06M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 3.88B
forwardPE -11.81203
floatShares 65.25M
sharesOutstanding 146.37M
sharesShort 12.93M
sharesShortPriorMonth 12.46M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.56%
heldPercentInstitutions 0.52%
Short Ratio help_outline 15.84%
shortPercentOfFloat 0.20%
impliedSharesOutstanding
bookValue 3.726
Price To Book help_outline 8.43
earningsQuarterlyGrowth
netIncomeToCommon -272.55M
trailingEps -1.91%
forwardEps -2.66%
enterpriseToEbitda -13.00
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.6 3Q 2024
institutionsCount 279
lastUpdated Nov. 7, 2024, 3:16 a.m.